CELLSAFE TO EXPAND BIOTECH ACTIVITIES IN INDONESIA

KUALA LUMPUR, April 23 (Bernama) -- Cellsafe International Group, a regional
stem cell biotechnology company, is to expand its biotechnology business and
research and development activities in Indonesia following a strategic
partnership with PT Kimia Farma TBK (Kimia Farma).

Cellsafe, through its subsidiary, PT Cellsafe International, Friday signed
a memorandum of understanding (MoU) with Kimia Farma, a leading integrated
healthcare services companies in Indonesia.

Cellsafe Executive Director Lau Kin Wai said the comprehensive partnership
involved co-branding and co-marketing arrangements that would allow the group to
harness the vast resources and indepth market knowledge of Kimia Farma.

Kimia Farma operates one of the largest network pharmacies in Indonesia,
with more than 400 outlets and owns more than 80 pharmacies in different
hospitals.

"Cellsafe has set up one of the largest stem cell cryogenic laboratories in
Indonesia. With this partnership, we will be constructing a new state-of-art
stem laboratory at a co-located facility with Kimia Farma Diagnostic," he told
reporters after the MoU signing.
-- BERNAMA


Attachments:
untitled-[2] 3.1 k [ text/html ] Download | View
Delete & Prev | Delete & Next
Move to: